{'text': 'FDA APPROVES IMLYGICTM (TALIMOGENE LAHERPAREPVEC) AS FIRST ONCOLYTIC VIRAL THERAPY IN THE US', 'publisher': {'href': 'http://www.multivu.com', 'title': 'MultiVu'}, 'created_at': 'Tue, 27 Oct 2015 07:00:00 GMT', 'description': 'FDA APPROVES IMLYGICTM (TALIMOGENE LAHERPAREPVEC) AS FIRST ONCOLYTIC VIRAL THERAPY IN THE US  MultiVu', 'url': 'https://news.google.com/rss/articles/CBMif0FVX3lxTE5POTNGdDVyRDVIcXVJbTVZbkpRNFZKanEzV24yenVPN2FoQi1zUXZrSUhFTjB6MG9kSjhLZk42XzM3RkFtcHkwMDZYeVZtYTJCMUlNaVg2Vm5OMGhHTk82YW5xX0FLeWN3emg0Qm5tMEVSWVZyV19nMW54ZFNKVlU?oc=5&hl=en-SG&gl=SG&ceid=SG:en'}
{'text': 'FDA Approves Imlygic , First Oncolytic Viral Therapy in the US', 'publisher': {'href': 'https://www.medscape.com', 'title': 'Medscape'}, 'created_at': 'Tue, 27 Oct 2015 07:00:00 GMT', 'description': 'FDA Approves Imlygic , First Oncolytic Viral Therapy in the US  Medscape', 'url': 'https://news.google.com/rss/articles/CBMiVkFVX3lxTE9vQnBoaENkS3RVYnBGN1M2RTNFbzh3VFpNT3ZhWmY5OUxEcHpWcVpYODd5ckhndVJPWGxWaDV3X0lfQVYxcTRITjZqQlhxNXgzRGVVRURR?oc=5&hl=en-US&gl=US&ceid=US:en'}
{'text': 'FDA-Approved Drug Uses Herpes Virus To Destroy Skin Cancer Tumors', 'publisher': {'href': 'https://www.cbsnews.com', 'title': 'CBS News'}, 'created_at': 'Tue, 27 Oct 2015 07:00:00 GMT', 'description': 'FDA-Approved Drug Uses Herpes Virus To Destroy Skin Cancer Tumors  CBS News', 'url': 'https://news.google.com/rss/articles/CBMiqgFBVV95cUxQMjdnczJPeXZ4THdEX3RFWFVqaWtpVHFHOXpVbDVQSVhOaFVPckVqUF9jQktpYTdKQzAzODZ5R0daa3VOZVZIX00yUkRhU1czb1JCNmg4WkRGX2pHMFdRWVJ0ZlZKX3k1akxyRXJzb1JNeTF2V0N1SkNQbHpFdDR1eDNjWGlzVXBVZHJ3NllaWTZDLXFYMGRZdGlXTG04cl9wWldVTXJTUTNOQdIBrwFBVV95cUxNdmRGWHhseWRSUmV0SkFZcWJNbzd1ampRSUxNYlhUclJqd3M3Zkl0c1dWNzltUThvWFBsemY2YXN1WkFsYlVuUlh6dFMyTFJvM0x2R0lveUVxSHpZekVwWktEWHhoTHVpZV9lTHlXejRBWjVVWFdIN0lyZ3FFRDRVUDI5NnFkWE5HY05JN3VMTk45WGMwNS1Gb3NiUWpEbGJYQUFINXhFYzVURks5aXlB?oc=5&hl=en-SG&gl=SG&ceid=SG:en'}
{'text': 'US approval for drug that turns herpes virus against cancer', 'publisher': {'href': 'https://www.theguardian.com', 'title': 'The Guardian'}, 'created_at': 'Tue, 27 Oct 2015 07:00:00 GMT', 'description': 'US approval for drug that turns herpes virus against cancer  The Guardian', 'url': 'https://news.google.com/rss/articles/CBMiqwFBVV95cUxPTW12aldmbFpoMHlQTjdnbjAyTFZQeXhaZVhUamJqRXdCS01aQWVxNFh2REJmU1JKX1l5MWdFVzFWaU5IZ1FlM3ZjbFFST3BkdDVpa1VWSE9MUE9TeTRXRFUwNmJzWHp2cDZ4azlyaGx1UlhUNEFRbWN3U3RJdVMybEVOMHhRd3pQYWQzVFJEVWxZWXZqRzNtS3dwTDlfcVdUMERRTEpPTFJ5VUU?oc=5&hl=en-US&gl=US&ceid=US:en'}
{'text': 'Cytokinetics, Incorporated (CYTK) Stock | Announces Positive Top-Line Results for Phase 2 Trial', 'publisher': {'href': 'https://warriortradingnews.com', 'title': 'Warrior Trading News'}, 'created_at': 'Wed, 28 Oct 2015 07:00:00 GMT', 'description': 'Cytokinetics, Incorporated (CYTK) Stock | Announces Positive Top-Line Results for Phase 2 Trial  Warrior Trading News', 'url': 'https://news.google.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?oc=5&hl=en-US&gl=US&ceid=US:en'}
